|
시장보고서
Gene Therapy--Industry Impact
|
Abstract
This research service discusses global advances in the field of gene therapy.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Introduction and History of Gene Therapy
- Introduction
- History of Gene Therapy
2 TECHNOLOGY AND APPLICATIONS VIEWPOINT
- Technology Primer
- Gene delivery--Vectors; Vehicles; Chemical and Physical Methods
- DNA Vaccines
- Additional Approaches
- Applications Analysis and Trends
- Targets Closest to Market
- Ocular Disorders--Macular Degeneration And Retinopathy
- Diabetes
- Cystic Fibrosis
- Rheumatoid Arthritis
- Types of Disorders
- Coronary Artery Disease
- Peripheral Artery Disease
- Cancer
- DNA Vaccines
- Assessment of Stakeholder Innovation and Technology Transfer
Opportunities--Influential Market Factors
- Mergers and Acquisitions Analysis
- Regulatory and Political Factors; Industry Trends
3 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Regulatory Hurdles
- Safety Issues and Regulatory Barriers
- Clinical Trials
- Technology or Product Development Restraints and Competing Technologies
- Technical Barriers
- Lack of Investor Confidence
- Gene Patents; Cost and Other Barriers
- Stem Cells and Other Cellular Therapies
- Analysis of Drivers
- Analysis of Funding Sources
- Features and Benefits of Gene Therapy
- Adoption Drivers for Gene Therapy
4 ASSESSMENT OF INNOVATIONS AND OPPORTUNITIES
- Innovative Developments in North America--Gene Therapy
- Targeting Cancer Cells with Antibody/Gene/Liposome Nanocomplex
- Polymer Delivers IL-12 Gene Therapy for Cancer
- Gene Therapy Promotes Blood Vessel Growth in Peripheral Artery Disease
- Lentiviral Vectors in Development
- p53 Gene Therapy for Esophageal Cancer
- Collagen Used as Target for Cancer Gene Therapy
- Nanotechnology Gene Therapy for Prostate Cancer
- Microbubbles Release Therapeutic Genes with Ultrasound
- Autoantigen-Plasmid Drug Promising against MS
- Zinc-Finger Protein Agent for Diabetic Neuropathy
- Gene Therapy for Epilepsy and Parkinson' s Disease
- Gene Therapy for Osteoarthritis
- Naked DNA for Cancer Gene Therapy
- Bare Metal Stents Deliver Gene Therapy to Treat Heart Disease
- Gene Immunotherapy--T Cells Transformed into Tumor Fighting Cells
- Emphysema Gene Therapy
- Hedgehog Agonist Gene for Diabetic Wound Healing
- Nanoparticles for DNA Delivery
- FGF Gene Therapy for Myocardial Ischemia
- Neurturin Gene Therapy for Parkinson' s Disease in Phase II Trials
- Light-Activated Gene Therapy Targets Knee Injuries; Other Tissue Repair
- New Lipid Molecule Holds Promise for Gene Therapy
- Additional Companies
- Innovative Developments in North America--DNA Vaccines
- Flu DNA Vaccine Candidate Delivered via Needle-Free Injection
- DOGS Cation Compound Enhances DNA Vaccines
- Short ISS DNA Sequences Stimulate Immune Responses
- Cell-Free Production of DNA for Flu Vaccine
- DNA Bird Flu Vaccine Protects Lab Animals
- DNA West Nile Vaccine Triggers Immune Response in Human Subjects
- HIV Vaccines
- Leukemia Vaccine Uses Tumor Cells Transfected with GM-CSF Gene
- Adenoviral TB Vaccine
- Clinical Trial for Ebola Vaccine
- Innovative Developments in Europe--Gene Therapy
- Gene Therapy for Critical Limb Ischemia
- Interferon Vector for Cutaneous Lymphoma
- Belgian and Dutch Companies Seek Spinal Gene Therapies
- Gene Therapy Appears to Cure Myeloid Disease in Human Subjects
- Additional Companies
- Innovative Developments in Europe--DNA Vaccines
- Adoptive Cell Therapy for Melanoma Vaccine
- E6 and E7 Genes in HPV Vaccine Clinical Trials
- Vaccine for Kidney Cancer
- HIV Vaccines
- Innovative Developments in the Asia Pacific Region
- Gendicine p53 Gene Therapy Follow-up
- Gene Therapy Successfully Treats Hemophilia
- Hepatocyte Growth Factor for Liver and Circulatory Disorders
- DNA Ointment for Atopic Dermatitis
5 PATENTS AND DATABASE OF KEY INDUSTRY PARTICIPANTS
- Patents
- Key Patents (2005)
- Key Patents (2006)
- Database of Key Industry Participants
- Corporate Sector
- Laboratories and Universities
6 DECISION SUPPORT DATABASE
- Database Tables
- Total Healthcare Expenditure--World (2002 to 2012)
- Government Healthcare Expenditure--World (2002 to 2012)
- Private Healthcare Expenditure--World (2002 to 2012)
|
